These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

689 related articles for article (PubMed ID: 32825423)

  • 1. P2X7 Receptors Amplify CNS Damage in Neurodegenerative Diseases.
    Illes P
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P2X7 receptors: channels, pores and more.
    Volonté C; Apolloni S; Skaper SD; Burnstock G
    CNS Neurol Disord Drug Targets; 2012 Sep; 11(6):705-21. PubMed ID: 22963440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P2X7 receptor: an emerging target in central nervous system diseases.
    Sperlágh B; Illes P
    Trends Pharmacol Sci; 2014 Oct; 35(10):537-47. PubMed ID: 25223574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ion channels on microglia: therapeutic targets for neuroprotection.
    Skaper SD
    CNS Neurol Disord Drug Targets; 2011 Feb; 10(1):44-56. PubMed ID: 21143139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Possible Causal Involvement of Neuroinflammatory, Purinergic P2X7 Receptors in Psychiatric Disorders.
    Zhang Y; Yin HY; Rubini P; Tang Y; Illes P
    Curr Neuropharmacol; 2022; 20(11):2142-2155. PubMed ID: 35236262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Astrocytic and Oligodendrocytic P2X7 Receptors Determine Neuronal Functions in the CNS.
    Zhao YF; Tang Y; Illes P
    Front Mol Neurosci; 2021; 14():641570. PubMed ID: 33642994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role and therapeutic targets of P2X7 receptors in neurodegenerative diseases.
    Zheng H; Liu Q; Zhou S; Luo H; Zhang W
    Front Immunol; 2024; 15():1345625. PubMed ID: 38370420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The neuroinflammatory astrocytic P2X7 receptor: Alzheimer's disease, ischemic brain injury, and epileptic state.
    Ahn YH; Tang Y; Illes P
    Expert Opin Ther Targets; 2023; 27(9):763-778. PubMed ID: 37712394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The purinergic P2X7 receptor as a potential drug target to combat neuroinflammation in neurodegenerative diseases.
    Calzaferri F; Ruiz-Ruiz C; de Diego AMG; de Pascual R; Méndez-López I; Cano-Abad MF; Maneu V; de Los Ríos C; Gandía L; García AG
    Med Res Rev; 2020 Nov; 40(6):2427-2465. PubMed ID: 32677086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of glutamate release mediated by extrasynaptic P2X7 receptors in animal models of neuropathic pain.
    Andó RD; Sperlágh B
    Brain Res Bull; 2013 Apr; 93():80-5. PubMed ID: 23047057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of P2X7 receptors in chronic pain disorders.
    Ren WJ; Illes P
    Purinergic Signal; 2022 Mar; 18(1):83-92. PubMed ID: 34799827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567.
    Bhattacharya A; Wang Q; Ao H; Shoblock JR; Lord B; Aluisio L; Fraser I; Nepomuceno D; Neff RA; Welty N; Lovenberg TW; Bonaventure P; Wickenden AD; Letavic MA
    Br J Pharmacol; 2013 Oct; 170(3):624-40. PubMed ID: 23889535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evolution of P2X7 antagonists with a focus on CNS indications.
    Rech JC; Bhattacharya A; Letavic MA; Savall BM
    Bioorg Med Chem Lett; 2016 Aug; 26(16):3838-45. PubMed ID: 27426304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of pannexin 1 with NMDA and P2X7 receptors in central nervous system pathologies: Possible role on chronic pain.
    Bravo D; Maturana CJ; Pelissier T; Hernández A; Constandil L
    Pharmacol Res; 2015 Nov; 101():86-93. PubMed ID: 26211949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethanol differentially modulates P2X4 and P2X7 receptor activity and function in BV2 microglial cells.
    Asatryan L; Ostrovskaya O; Lieu D; Davies DL
    Neuropharmacology; 2018 Jan; 128():11-21. PubMed ID: 28943285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleotide signaling in astrogliosis.
    Franke H; Illes P
    Neurosci Lett; 2014 Apr; 565():14-22. PubMed ID: 24103370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging role of P2X7 receptors in CNS health and disease.
    Tewari M; Seth P
    Ageing Res Rev; 2015 Nov; 24(Pt B):328-42. PubMed ID: 26478005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The microglial ATP-gated ion channel P2X7 as a CNS drug target.
    Bhattacharya A; Biber K
    Glia; 2016 Oct; 64(10):1772-87. PubMed ID: 27219534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The NADPH oxidase pathway is dysregulated by the P2X7 receptor in the SOD1-G93A microglia model of amyotrophic lateral sclerosis.
    Apolloni S; Parisi C; Pesaresi MG; Rossi S; Carrì MT; Cozzolino M; Volonté C; D'Ambrosi N
    J Immunol; 2013 May; 190(10):5187-95. PubMed ID: 23589615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A current review on P2X7 receptor antagonist patents in the treatment of neuroinflammatory disorders: a patent review on antagonists.
    Soni S; Lukhey MS; Thawkar BS; Chintamaneni M; Kaur G; Joshi H; Ramniwas S; Tuli HS
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jul; 397(7):4643-4656. PubMed ID: 38349395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.